Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors [Phase 1]
Phase 1 study evaluating gefitinib (ZD1839) in combination with irinotecan and vincristine in pediatric patients with refractory solid tumor…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Safety Study of Infusion of SGT-53 to Treat Solid Tumors [Phase 1]
Completion of a Phase 1 safety study evaluating infusion of SGT-53 for treating solid tumors, sponsored by SynerGene Therapeutics.
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating Urelumab (BMS-663513) in patients with advanced/metastatic solid tumors and relapsed/refractory B-cell non-Hodgkin'…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 open-label trial evaluating ruxolitinib in combination with chemotherapy for advanced solid tumors, terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309 [Phase 1]
Phase 1 study assessing safety, pharmacokinetics, and pharmacodynamics of PQR309 in patients with advanced solid tumors; the trial has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of GDC-0425 with and without gemcitabine in patients with refractory…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy [Phase 3]
Phase 3 trial evaluating whether adding olanzapine to standard antiemetic therapy improves prevention of chemotherapy-induced nausea and vom…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors [Phase 1]
Phase 1 safety and tolerability update of SNS-314 in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 study by MedImmune evaluating safety and antitumor activity in adults with advanced solid tumors, including advanced recurrent ovari…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001) [Phase 1]
Phase 1 dose-escalation trial of dalotuzumab (MK-0646) in advanced solid tumors and multiple myeloma completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
The trial evaluating Retacrit (epoetin zeta), a biosimilar, for chemotherapy-induced symptomatic anemia in hematology and oncology has compl…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer [Phase 1]
Phase 1 dose-escalation study of TAK-117 (MLN1117) in subjects with advanced metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Open Label Study of DS-5573a [Phase 1]
Open-label Phase 1 study of DS-5573a by Daiichi Sankyo in patients with advanced solid malignant tumors has been terminated.
-
CLINICAL_TRIALS research · 2017-02-14Clinical Trial Update: Phase I Study of CS-7017 and Bexarotene [Phase 1]
Phase I trial of CS-7017 in combination with Bexarotene for solid tumors, lymphoma, and multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating STM-434 alone or with liposomal doxorubicin in ovarian cancer, fallopian tube cancer, endometrial cancer, and other…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Testing Two Different Intensities of an Intervention to Enhance REsilience and to Reduce SupportIve Care Needs in Cancer Patients [NA]
A completed clinical trial tested two intensities of an intervention aimed at improving resilience and reducing supportive care needs in adu…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors [Phase 1]
Phase 1 trial of HuMax-IL8 for patients with advanced malignant solid tumors has completed, providing early safety and tolerability data.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies [Phase 1]
Phase 1 study assessing pharmacokinetic interactions between capecitabine and BMS-247550 in patients with advanced malignancies; the update …
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Administration of BIIB028 to Subjects With Solid Tumors [Phase 1]
This entry reports the completion of a Phase 1 trial of BIIB028 in adults with advanced solid tumors, summarizing safety, tolerability, and …
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Study of KRN951 in Patients With Solid Tumors [Phase 1]
A Phase 1 study of the investigational agent KRN951 in patients with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety [Phase 1]
This Phase 1 study evaluated the effect of a single dose of NKTR-102 (etirinotecan pegol) on QTc interval and assessed pharmacokinetics and …
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies [Phase 1]
This entry reports completion of a Phase 1 study evaluating safety, tolerability, pharmacokinetics and activity of Oraxol in adults with adv…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors [Phase 1]
Phase 1 clinical trial update for MSC2156119J (c-Met inhibitor) in Japanese subjects with solid tumors; study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 study of GDC-0917 in patients with refractory solid tumors or lymphoma has completed. The study assessed safety, tolerability, and p…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 trial evaluating GDC-0980 in patients with refractory solid tumors or Non-Hodgkin lymphoma has completed.